A Phase II Randomized Clinical Trial (MC1623) of Concurrent Chemotherapy and Standard (60-66 Gy) Vs. High (72 Gy) Dose Proton Beam Therapy (PBT) for Patients with Unresectable, Stage II/111 Non -Small Cell Lung Cancer (NSCLC)
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要